GSK emerging sales surge; Pfizer’s China strategy
What with all the job-cuts news this week, we weren’t able to get to hit much more than the high points of Big Pharma’s latest earnings reports. Here’s a roundup of related news for your reading pleasure this weekend. Like several of its rivals, Sanofi-Aventis is expected to post a 3.5 percent rise in fourth-quarter adjusted net profit next week but give a prudent forecast for 2010 when battles with generic rivals will intensify.
